SpringWorks Therapeutics Inc (NAS:SWTX)
$ 36.12 -0.08 (-0.22%) Market Cap: 2.68 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 4.71 GF Score: 40/100

SpringWorks Therapeutics Inc at H.C. Wainwright Precision Oncology Conference (Virtual) Transcript

Nov 14, 2022 / 03:30PM GMT
Release Date Price: $26.18 (+4.80%)
Robert Burns
H.C. Wainwright & Co., LLC - Analyst

Welcome to our next fireside chat with SpringWorks Therapeutics. I'm Robert Burns, Managing Director and Senior Biotech Analyst at H.C. Wainwright. And I'm joined today by Badreddin Edris, the Chief Operating Officer of SpringWorks. Badreddin, thank you for joining us today.

Badreddin Edris
SpringWorks Therapeutics, Inc. - COO

Thanks for having us, Rob. We appreciate the opportunity to be here.

Questions & Answers

Robert Burns
H.C. Wainwright & Co., LLC - Analyst

So I will just dive in. And so for those who may be unfamiliar with SpringWorks, can you provide a brief overview of the company as well as its pipeline?

Badreddin Edris
SpringWorks Therapeutics, Inc. - COO

Yes, absolutely. Happy to do so and happy to have the opportunity to share the story at a high level during what continues to be a pivotal year as we come to the end of it and look forward to what comes next. So for those tuning in who

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot